{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:51:52Z","timestamp":1776477112217,"version":"3.51.2"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82371024"],"award-info":[{"award-number":["82371024"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100018625","name":"Science and Technology Innovation Plan Of Shanghai Science and Technology Commission","doi-asserted-by":"publisher","award":["22Y11910300"],"award-info":[{"award-number":["22Y11910300"]}],"id":[{"id":"10.13039\/501100018625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>To investigate the synergistic effects of duration of glaucoma and number of medications on meibomian gland orifice obstruction severity in glaucoma patients, aiming to optimize therapeutic strategies for ocular surface protection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective study analyzed 120 glaucoma patients with concurrent MGD. Meibomian gland orifice obstruction was scored using standardized criteria. The relationship between obstruction scores and clinical factors was evaluated using Spearman correlation and generalized linear modeling.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Significant correlations were found between MG orifice obstruction score and duration of glaucoma (<jats:italic>r<\/jats:italic>\u2009=\u20090.309, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), number of medications (<jats:italic>r<\/jats:italic>\u2009=\u20090.340, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), number of preserved eye drop products (<jats:italic>r<\/jats:italic>\u2009=\u20090.300, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and duration of medication (<jats:italic>r<\/jats:italic>\u2009=\u20090.398, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Generalized linear modeling revealed significant main effects of duration of glaucoma and number of medications (<jats:italic>P<\/jats:italic>\u2009=\u20090.012 and <jats:italic>P<\/jats:italic>\u2009=\u20090.005), with a significant interaction (<jats:italic>P<\/jats:italic>\u2009=\u20090.020). After 3 years of glaucoma, any medication regimen significantly increased obstruction scores compared to no treatment (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Triple or quadruple therapy showed significantly higher obstruction scores versus no medication (<jats:italic>P<\/jats:italic>\u2009=\u20090.002 and <jats:italic>P<\/jats:italic>\u2009=\u20090.008).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Duration of glaucoma and number of medications synergistically worsen MG orifice obstruction, with a critical threshold after one year of disease. These findings suggest the importance of reducing medication burden in long-term glaucoma patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12886-025-04378-0","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:26:55Z","timestamp":1760081215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of risk factors associated with meibomian gland orifice obstruction severity in glaucoma patients: a clinical investigation"],"prefix":"10.1186","volume":"25","author":[{"given":"Yue","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wushuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"issue":"4","key":"4378_CR1","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3760\/cma.j.cn112142-20230114-00023","volume":"59","author":"Chinese Branch of the Asian Dry Eye Society; Ocular Surface and Tear Film Diseases Group of Ophthalmology Committee of Cross","year":"2023","unstructured":"Chinese Branch of the Asian Dry Eye Society; Ocular Surface and Tear Film Diseases Group of Ophthalmology Committee of Cross\u2013Straits Medicine Exchange Association; Ocular Surface and Dry Eye Group of Chinese Ophthalmologist Association. Chinese expert consensus on meibomian gland dysfunction: definition and classification (2023). Zhonghua Yan Ke Za Zhi. 2023;59(4):880\u20137. https:\/\/doi.org\/10.3760\/cma.j.cn112142-20230114-00023.","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"6","key":"4378_CR2","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S0161-6420(03)00262-8","volume":"110","author":"PY Lin","year":"2003","unstructured":"Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM. Prevalence of dry eye among an elderly Chinese population in Taiwan. Ophthalmology. 2003;110(6):1096\u2013101. https:\/\/doi.org\/10.1016\/S0161-6420(03)00262-8.","journal-title":"Ophthalmology"},{"issue":"3","key":"4378_CR3","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/sj.eye.6703101","volume":"23","author":"Y Jie","year":"2009","unstructured":"Jie Y, Xu L, Wu YY, Jonas JB. Prevalence of dry eye among adult Chinese in the Beijing eye study. Eye. 2009;23(3):688\u201393. https:\/\/doi.org\/10.1038\/sj.eye.6703101.","journal-title":"Eye"},{"issue":"1","key":"4378_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/01.IOP.0000153028.08506.47","volume":"21","author":"T Kojima","year":"2005","unstructured":"Kojima T, Dogru M, Matsumoto Y, Goto E, Tsubota K. Tear film and ocular surface abnormalities after eyelid tattooing. Ophthalmic Plast Reconstr Surg. 2005;21(1):69\u201371. https:\/\/doi.org\/10.1097\/01.IOP.0000153028.08506.47.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"4378_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1199440","volume":"11","author":"B Huang","year":"2023","unstructured":"Huang B, Fei F, Wen H, et al. Impacts of gender and age on meibomian gland in aged people using artificial intelligence. Front Cell Dev Biol. 2023;11:1199440. https:\/\/doi.org\/10.3389\/fcell.2023.1199440.","journal-title":"Front Cell Dev Biol"},{"key":"4378_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31823f0977","author":"JJK Siak","year":"2012","unstructured":"Siak JJK, Tong L, Wong WL, et al. Prevalence and risk factors of meibomian gland dysfunction: the Singapore Malay eye study. Cornea. 2012. https:\/\/doi.org\/10.1097\/ICO.0b013e31823f0977.","journal-title":"Cornea"},{"issue":"4","key":"4378_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jtos.2019.06.002","volume":"17","author":"J Bu","year":"2019","unstructured":"Bu J, Wu Y, Cai X, et al. Hyperlipidemia induces meibomian gland dysfunction. Ocul Surf. 2019;17(4):777\u201386. https:\/\/doi.org\/10.1016\/j.jtos.2019.06.002.","journal-title":"Ocul Surf"},{"issue":"12","key":"4378_CR8","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1016\/j.ajpath.2020.09.002","volume":"190","author":"X He","year":"2020","unstructured":"He X, Zhao Z, Wang S, et al. High-fat diet\u2013induced functional and pathologic changes in lacrimal gland. Am J Pathol. 2020;190(12):2387\u2013402. https:\/\/doi.org\/10.1016\/j.ajpath.2020.09.002.","journal-title":"Am J Pathol"},{"issue":"10","key":"4378_CR9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/IJG.0000000000002465","volume":"33","author":"EM Messmer","year":"2024","unstructured":"Messmer EM, Baudouin C, Benitez-Del-Castillo JM, et al. Expert consensus recommendations for the management of ocular surface inflammation in patients with glaucoma. J Glaucoma. 2024;33(10):715\u201327. https:\/\/doi.org\/10.1097\/IJG.0000000000002465.","journal-title":"J Glaucoma"},{"issue":"22","key":"4378_CR10","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.2174\/0929867325666181009153212","volume":"26","author":"R Mastropasqua","year":"2019","unstructured":"Mastropasqua R, Agnifili L, Mastropasqua L. Structural and molecular tear film changes in glaucoma. CMC. 2019;26(22):4225\u201340. https:\/\/doi.org\/10.2174\/0929867325666181009153212.","journal-title":"CMC"},{"issue":"4","key":"4378_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/ICO.0000000000001489","volume":"37","author":"JH Kim","year":"2018","unstructured":"Kim JH, Shin YU, Seong M, Cho HY, Kang MH. Eyelid changes related to meibomian gland dysfunction in early Middle-Aged patients using topical glaucoma medications. Cornea. 2018;37(4):421\u20135. https:\/\/doi.org\/10.1097\/ICO.0000000000001489.","journal-title":"Cornea"},{"issue":"6","key":"4378_CR12","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/ICO.0b013e3181c325b2","volume":"29","author":"RD Fechtner","year":"2010","unstructured":"Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC, Jasek MC. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea. 2010;29(6):618\u201321. https:\/\/doi.org\/10.1097\/ICO.0b013e3181c325b2.","journal-title":"Cornea"},{"issue":"2","key":"4378_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/14740338.2024.2436062","volume":"24","author":"G Holl\u00f3","year":"2025","unstructured":"Holl\u00f3 G. Ocular hyperemia associated with topical glaucoma medication: understanding and differentiating clinical appearance and underlying mechanisms. Exp Opin Drug Saf. 2025;24(2):145\u201356. https:\/\/doi.org\/10.1080\/14740338.2024.2436062.","journal-title":"Exp Opin Drug Saf"},{"key":"4378_CR14","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jtos.2023.11.003","volume":"30","author":"I Moreno","year":"2023","unstructured":"Moreno I, Verma S, Gesteira TF, Coulson- Thomas VJ. Recent advances in age-related meibomian gland dysfunction (ARMGD). Ocul Surf. 2023;30:298\u2013306. https:\/\/doi.org\/10.1016\/j.jtos.2023.11.003.","journal-title":"Ocul Surf"},{"key":"4378_CR15","unstructured":"BOrth FO, Doms SG, Lamoureux E, Franzco V, Franzco JGC. Prevalence of signs and symptoms of ocular surface disease in individuals treated and not treated with glaucoma medication. Clinical and Experimental Ophthalmology. Published online 2012."},{"key":"4378_CR16","doi-asserted-by":"crossref","unstructured":"Erb C, Gast U, Schremmer D. German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye. Graefes Arch Clin Exp Ophthalmol. Published online 2008.","DOI":"10.1007\/s00417-008-0881-9"},{"key":"4378_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100916","volume":"83","author":"C Baudouin","year":"2021","unstructured":"Baudouin C, Kolko M, Melik-Parsadaniantz S, Messmer EM. Inflammation in glaucoma: from the back to the front of the eye, and beyond. Prog Retin Eye Res. 2021;83:100916. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100916.","journal-title":"Prog Retin Eye Res"},{"key":"4378_CR18","doi-asserted-by":"crossref","unstructured":"Baudouin C, Renard JP, Nordmann JP et al. Prevalence and risk factors for ocular surface disease among patients treated over the long term for glaucoma or ocular hypertension. Published online 2012.","DOI":"10.5301\/ejo.5000181"},{"issue":"3","key":"4378_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jtos.2018.03.002","volume":"16","author":"WA Wong","year":"2018","unstructured":"Wong WA, Wang MTM, Liu K, Prime ZJ, Danesh Meyer HV, Craig JP. Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current Understanding of dry eye. Ocul Surf. 2018;16(3):289\u201393. https:\/\/doi.org\/10.1016\/j.jtos.2018.03.002.","journal-title":"Ocul Surf"},{"issue":"8","key":"4378_CR20","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1097\/ICO.0000000000000838","volume":"35","author":"E Uzunosmanoglu","year":"2016","unstructured":"Uzunosmanoglu E, Mocan MC, Kocabeyoglu S, Karakaya J, Irkec M. Meibomian gland dysfunction in patients receiving long-term glaucoma medications. Cornea. 2016;35(8):1112\u20136. https:\/\/doi.org\/10.1097\/ICO.0000000000000838.","journal-title":"Cornea"},{"issue":"1","key":"4378_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.joco.2018.07.003","volume":"31","author":"K Asiedu","year":"2019","unstructured":"Asiedu K, Abu SL. The impact of topical intraocular pressure lowering medications on the ocular surface of glaucoma patients: a review. J Curr Ophthalmol. 2019;31(1):8\u201315. https:\/\/doi.org\/10.1016\/j.joco.2018.07.003.","journal-title":"J Curr Ophthalmol"},{"key":"4378_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jtos.2022.07.007","volume":"26","author":"F Fineide","year":"2022","unstructured":"Fineide F, Lagali N, Adil MY, et al. Topical glaucoma medications \u2013 clinical implications for the ocular surface. Ocul Surf. 2022;26:19\u201349. https:\/\/doi.org\/10.1016\/j.jtos.2022.07.007.","journal-title":"Ocul Surf"},{"key":"4378_CR23","doi-asserted-by":"publisher","unstructured":"Baudouin C, Pflugfelder. Challenges in the clinical measurement of ocular surface disease in glaucoma patients. OPTH Published Online November 2011:1575. https:\/\/doi.org\/10.2147\/OPTH.S24410","DOI":"10.2147\/OPTH.S24410"},{"issue":"7","key":"4378_CR24","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/ceo.13814","volume":"48","author":"I Mohammed","year":"2020","unstructured":"Mohammed I, Kulkarni B, Faraj LA, Abbas A, Dua HS, King AJ. Profiling ocular surface responses to preserved and non-preserved topical glaucoma medications: a 2-year randomized evaluation study. Clin Exper Ophthalmol. 2020;48(7):973\u201382. https:\/\/doi.org\/10.1111\/ceo.13814.","journal-title":"Clin Exper Ophthalmol"},{"issue":"4","key":"4378_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","volume":"29","author":"C Baudouin","year":"2010","unstructured":"Baudouin C, Labb\u00e9 A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010;29(4):312\u201334. https:\/\/doi.org\/10.1016\/j.preteyeres.2010.03.001.","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"4378_CR26","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1089\/jop.2008.0140","volume":"25","author":"SP Epstein","year":"2009","unstructured":"Epstein SP, Chen D, Asbell PA. Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells. J Ocul Pharmacol Ther. 2009;25(5):415\u201324. https:\/\/doi.org\/10.1089\/jop.2008.0140.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"6","key":"4378_CR27","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/ICO.0000000000001181","volume":"36","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Kam WR, Liu Y, Chen X, Sullivan DA. Influence of pilocarpine and timolol on human meibomian gland epithelial cells. Cornea. 2017;36(6):719\u201324. https:\/\/doi.org\/10.1097\/ICO.0000000000001181.","journal-title":"Cornea"},{"key":"4378_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.exer.2018.02.009","volume":"170","author":"X Han","year":"2018","unstructured":"Han X, Liu Y, Kam WR, Sullivan DA. Effect of brimonidine, an \u03b12 adrenergic agonist, on human meibomian gland epithelial cells. Exp Eye Res. 2018;170:20\u20138. https:\/\/doi.org\/10.1016\/j.exer.2018.02.009.","journal-title":"Exp Eye Res"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04378-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04378-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04378-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T11:52:37Z","timestamp":1760356357000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-04378-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4378"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04378-0","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol adhered to the tenets of the Declaration of Helsinki and received approval from the Ethics Committee of the Eye & ENT Hospital of Fudan University. The requirement for informed consent was waived due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"560"}}